Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur.
Fifteen women with severe vertebral osteoporosis were treated with daily parathyroid peptide (hPTH) plus hormone-replacement co-therapy (HRT) for 1 year. Eight other patients were randomized to HRT alone. Co-therapy with hPTH and HRT resulted in an impressive mean treatment response at the spine (du...
Main Authors: | Reeve, J, Mitchell, A, Tellez, M, Hulme, P, Green, JR, Wardley-Smith, B, Mitchell, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Human parathyroid peptide treatment of vertebral osteoporosis.
by: Reeve, J, et al.
Published: (1993) -
Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
by: Reeve, J, et al.
Published: (1987) -
A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
by: Reeve, J, et al.
Published: (1986) -
Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
by: Tellez, M, et al.
Published: (1995) -
Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.
by: Scoutellas, V, et al.
Published: (1999)